Baxalta Inc

Stock Update (NASDAQ:CTIC): CTI BioPharma Corp And Baxalta Complete Submission Of New Drug Application For Pacritinib For Unmet Medical Need In Myelofibrosis

CTI BioPharma Corp. (NASDAQ:CTIC) and Baxalta Inc(NYSE:BXLT) announced the completion of the rolling submission of the New Drug Application (NDA) to theU.

Corey Williams — January 5, 2016, 1:42 AM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts